ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/21/2025
Back to search
Official data from USPTO
TRANSINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRANSINE
ST13
US500000079316838Class
1, 5, 42
Filing
79316838
Registration
6816931
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/27/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/11/2021
Registration date
08/16/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
03/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
O'BRIEN, ELIZABETH
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Harness Therapeutics Limited
Transine Therapeutics Limited
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for scientific purposesother than for medical or veterinary use; chemicals for research usenucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research usenucleic acid sequences for laboratory usenucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNAreagents for scientific purposesother than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNAenzymes for scientific and research purposes; molecular biology research tools in the nature of biologicalchemical and biochemical reagents for research use
Class 5
Pharmaceutical preparations for the treatment and prevention of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; biologicalchemical and biochemical reagentsDNA and RNA sequences and gene editing enzymesall for medical use; DNA and RNA products for medical usenucleic acid sequences for medical purposes; therapeutic DNA and RNAnucleic acid sequences for medical purposes
Class 42
Scientific and technological services and research and design relating theretonamely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; researchdevelopmenttesting and analysis for scientific research purposes in the field of genomicsDNA and RNA sequencinggene synthesisgene identificationgene cloninggene expressiongene mapping; scientific research in the field of molecular biologynext generation sequencinghigh-throughput sequencing and bioinformatics; gene editing services for scientific research purposes; DNA and RNA modelling servicesnamely genetic mapping for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating and providing databases or collections of information on normal and mutated genes for scientific research purposes; scientific services relating to the discoverypreclinical and clinical development of therapeutic productsnamely therapeutic DNA and RNA; consultancy and advisory services relating to the aforesaid services; research and development of synthetic DNARNAgenes and oligonucleotides for others
Publications
History of USPTO decisions and trademark events.
31 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/26/2022
FIMP
FINAL DISPOSITION PROCESSED
11/26/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/16/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/26/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2022
PUBO
PUBLISHED FOR OPPOSITION
05/31/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/11/2022
ALIE
ASSIGNED TO LIE
04/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2022
DOCK
ASSIGNED TO EXAMINER
03/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2022
RFNT
REFUSAL PROCESSED BY IB
10/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/16/2021
RFRR
REFUSAL PROCESSED BY MPU
09/16/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/02/2021
CNRT
NON-FINAL ACTION WRITTEN
09/01/2021
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
08/27/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/13/2021
CNRT
NON-FINAL ACTION WRITTEN
08/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/10/2021
DOCK
ASSIGNED TO EXAMINER
08/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens TRANSINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.